Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(INFI, MSLP.OB, SYNT, ISYS, ANEN) Stock Update from

|Includes: Anaren, Inc. (ANEN), INFI, ISYS, SYNT




Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) reporteed that results from its Phase 2 study of IPI-504, a novel IV-administered Hsp90 chaperone inhibitor, in patients with advanced non-small cell lung cancer (NSCLC) were published in the Journal of Clinical Oncology (Sequist et. al., J Clin Oncol. doi: 10.1200/JCO.2010.30.8338, 2010).

These data, presented previously at the 2010 Annual Meeting of the American Society of Clinical Oncology (OTC:ASCO), documented for the first time the activity of an Hsp90 inhibitor in a molecularly defined cohort of patients with advanced NSCLC. In the study, IPI-504 was generally well tolerated and demonstrated clinical activity, particularly among patients with oncogenic anaplastic lymphoma kinase (NYSE:ALK) gene rearrangements.



MusclePharm Corporation (OTCBB:MSLP) is one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products.

** selected MSLP as the Supplement Company of the Month for October. recognizes leading supplement companies with products and services that are making a positive impact on the industry and their consumers each month.

MSLP is currently ranked #14 on’s best selling Company list out of 563 companies. MSLP continues to increase its dominate brand presence in the sports nutrition world with over 1,000 customer product reviews and an average rating of 9.2 out 10.0 on

"MusclePharm's ads are in all the magazines with some of the biggest names not only in bodybuilding, but the entire sports world. You see their logo on every MMA event and their products are amongst the most popular in the industry today," commented Jeremy Deluca,'s President. " is recognizing MusclePharm for their accomplishments and their loyal customer base by featuring them as the Supplement Company of the Month."

Furthermore, MSLP has entered into a distribution agreement with TapouT to launch a MusclePharm apparel line that includes t-shirts, sweat suits, shorts and other active wear items.

More about MSLP at


Syntel (Nasdaq:SYNT), a global information technology services and Knowledge Process Outsourcing (KPO) firm, reported it has been named to Software Magazine's Software 500 ranking of the world's largest software and services providers.


Integral Systems, Inc., (Nasdaq:ISYS) reported at the SATCON Satellite and Content Delivery Conference & Expo, that its wholly-owned subsidiary, Newpoint Technologies, has partnered with Australia-based Clearbox Systems to provide the COMPASS Redundancy Manager Module for the Compass Network Management System (NYSE:NMS).

The new module provides automated configuration of redundant systems and dynamically prioritizes and recovers traffic when network failures occur. The increased layer of redundancy ensures network uptime, resulting in reduced costs, Service Level Agreement (NYSE:SLA) commitments are met and increased Quality of Service (QoS).


3D Systems (Nasdaq:TDSC) has entered into an agreement with netfabb GmbH to resell netfabb's entire product portfolio of Studio and Cloud Solutions software with its 3D Production Systems, 3Dproparts(tm) and 3D Printers world-wide.


Anaren, Inc. (Nasdaq:ANEN) will present to the investment community during the "Piper Jaffray Technology, Media & Telecommunications Conference" in New York City at The Westin New York at Times Square Hotel, 270 West 43rd Street, on Tuesday, November 9th.


Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).